InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（8 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
8
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Harris Todd, 董事长兼首席执行官. Director active across 1 company, notably Tyra Biosciences, Inc.. In total, 21 filings have been published. Split: 0 buy · 8 sells. Total volume traded: €2.9m. History available since 15 March 2022. The latest transaction was disclosed on 13 March 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Harris Todd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报21 总计
1,463 股@ US$9.1290.4% 占其流量Common StockSEC:0001193125-26-111083:0
1,241 股@ US$9.7750.4% 占其流量Common StockSEC:0000950170-25-041551:0
43,636 股@ US$27.014335.9% 占其流量Common StockSEC:0000950170-24-116345:0
10,035 股@ US$24.31197.4% 占其流量Common StockSEC:0000950170-24-115432:0
500 股@ US$24.000.4% 占其流量Common StockSEC:0000950170-24-111702:0
10,092 股@ US$24.12577.2% 占其流量Common StockSEC:0000950170-24-109410:0
3,500 股@ US$24.002.5% 占其流量Common StockSEC:0000950170-24-108533:0
1,350 股@ US$6.5790.3% 占其流量Common StockSEC:0000950170-24-107399:0
1,880 股@ US$6.5790.4% 占其流量Common StockSEC:0000950170-24-033814:0
78,996 股@ US$16.445939.4% 占其流量Common StockSEC:0000950170-24-011879:0
1,421 股@ US$6.5794.6% 占其流量Common StockSEC:0001209191-23-050092:0
2,978 股@ US$16.97721.5% 占其流量Common StockSEC:0001209191-23-039807:0
3,316 股@ US$16.491.6% 占其流量Common StockSEC:0001209191-23-038945:0
7,927 股@ US$2.250.5% 占其流量Common StockSEC:0001209191-23-037613:0
2,000 股@ US$2.250.1% 占其流量Common StockSEC:0001209191-23-023402:0
1,420 股@ US$2.250.1% 占其流量Common StockSEC:0001209191-23-021947:0
170 股@ US$2.250.0% 占其流量Common StockSEC:0001209191-23-021443:0
12,393 股@ US$2.250.9% 占其流量Common StockSEC:0001209191-23-020848:0
1,808 股@ US$6.5790.4% 占其流量Common StockSEC:0001209191-23-019793:0
3,125 股@ US$8.52550.8% 占其流量Common StockSEC:0001209191-22-049213:0
34,007 股Common StockSEC:0000899243-21-036426:0
21 条申报中的 21 条
About Harris Todd
Harris Todd is President-Directeur Général and is linked to Tyra Biosciences, Inc. (XNAS) as President and CEO. He has 21 filings in total, and across the recent filings tracked, the prevailing transaction type is sell, with 0 EUR of buys and 2908878 EUR of sells between 2021-09-17 and 2026-03-17.
